US Edition
CRISPR-based therapies signal a new direction in tackling infectious diseases
Summary by Clinical Trials Arena
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
CRISPR-based therapies signal a new direction in tackling infectious diseases
As antimicrobial resistance (AMR) escalates and chronic viral infections like human immunodeficiency virus (HIV) and herpes remain without curative treatments, clustered regularly interspaced short palindromic repeats (CRISPR)-based therapeutics are emerging as a promising new strategy in the infectious disease space.The post CRISPR-based therapies signal a new direction in tackling infectious diseases appeared first on Clinical Trials Arena.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
